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ChEBI, IEDB and their relationship.
What ChEBI is: Chemical Entities of Biological Interest (ChEBI) is a
curated database of small chemical entities important in biosystems [1]. Its
focus is on entities of no more than 1,500 atomic mass units.
ChEBI evolution: Since its inception in 2004, ChEBI has evolved from an
illustrated dictionary of terms into a semantically rich knowledge base with
an internal hierarchy that organises entities by their molecular structure
types and potential rôles. Its 2009 acquisition of the BioFocus drug
discovery dataset [2] exponentially increased the number of entities from
20,000 to 500,000. ChEBI continues to develop automatic curation
protocols to maintain the high standards characteristic of the smaller
dataset, while the number of manually curated entities continues to rise.
The ChEBI-IEDB collaboration: The Immune Epitope and Analysis
Resource (IEDB) is a project supported by contract from the National
Institute of Allergy and Infectious Diseases (NIAID) with the aim of making
epitope-related data on infectious diseases and immune disorders freely
available to researchers worldwide [3]. In addition, the IEDB houses
cutting-edge analytical tools [4]. In June 2009, ChEBI began working with
the IEDB on a project aimed at incorporating into ChEBI, by manual
curation, a pilot subset of immunologically important chemical substances
that had been identified as immune epitopes.
IEDB epitopes in ChEBI – the curation process: A list of 1,200
entities was provided by the IEDB, each with one or more PMIDs (PubMed
(unique) Identifiers) for publications describing contexts in which the
immune epitope status of the structure had been assayed. These chemical
units were treated in one of three ways: -
(1) Where the entity already existed in ChEBI, the PMID was entered into the ChEBI
database and automatically hyperlinked to the PubMed site;
(2) Entities automatically downloaded as part of the BioFocus dataset required
definitions, ontology specifications, IUPAC names, synonyms and registry numbers for the
various databases linked to ChEBI;
(3) New ChEBI identification numbers were generated for entities that did not already
exist.
In addition to the data items mentioned in (1) and (2) above, structures were
drawn or generated using ChEBI’s in-house tools. The rôles played by these
structures (e.g. immunogen, antigen, epitope and hapten) were also curated.
The status quo: In the year since the ChEBI-IEDB collaboration began,
the pilot 1,200 entities have all been fully curated. Of this number, 50%
were newly created for this project, and included a number of new rôles
related to immunology. 250 new citations were added to ChEBI from this
subset of IEDB data, covering epitopes relating to a variety of entities
including antibiotics, organic radicals, oligosaccharides, norligans, transition
metal complexes, alkaloids and amino acids. The IEDB continues to request
that new structures be processed by ChEBI as new categories of immune
epitope-related publications are curated. Approximately 100 structures per
month are processed by ChEBI for the IEDB.
The significance of the project: The increasing global prevalence of
immune-related diseases, and the complexity of the contributing factors [5,
6], underscore an ever-increasing need for cross-talk among the various
scientific disciplines, and makes ChEBI involvement in this project
particularly relevant. The ChEBI-IEDB teamwork here described illustrates
the mutual advantages to be gained from such joint endeavours: while the
incorporation of IEDB items into ChEBI has effected a significant
enrichment of the latter’s database content and ontology, IEDB has
profited from the ChEBI team’s expertise in describing non-peptidic
epitopes and from the structure tree lay-out and the multiplicity of
synonyms used in ChEBI, which facilitate a simplified search process. The
IEDB has recently updated its search interface to make the most of its
collaboration with ChEBI.
Conclusion: In identifying and curating these non-classical epitopes, we
have highlighted the broad array of non-peptidic epitopes in existence.
To date, we have identified over 20 categories of such entities, including
antibiotics, resins, food additives and nucleic acid derivatives, in addition
to the eight categories depicted in figures 1-8 of this poster. In so doing,
we have demonstrated how collaboration among curators working on
different databases can lead to reciprocal benefits combined with an
enhanced service to our users.
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Broad range of non-peptidic epitopes unearthed by IEDB and represented in ChEBI
Fig.9: View of ChEBI ontology relating to a mimotope
(molecule whose structure mimics that of an epitope).
‘Fig.1: Nickel ion hapten – Ni2+ (seen here in ChEBI:53001)
represents the most common contact sensitiser in the
industrialised world. It acts as a hapten (partial antigen),
capable of inducing an immune response upon binding to
MHC-associated proteins.
Fig.2:‘Saccharide antigen  (ChEBI: 59384) - a
branched tetrasaccharide typical of many bacterial cell
wall-derived antigens.
Fig.6: ‘Organic heterocycle epitope (ChEBI: 59525) - a
ladder-like polycyclic ether characteristic of certain marine
toxins.
‘Fig.3: Amino acid-based epitope (ChEBI: 59565) –
an alanine derivative.
‘Fig.4: Fatty acid-based epitope (ChEBI: 45573) - a butyric
(butanoic) acid-derived epitope.
Fig.8: ‘Glycosphingolipid epitope  (ChEBI: 466659) -
an α-D-galactose-derived glycophytoceramide, the
most potent agonistic antigen of the T cell receptor
of natural killer T cells.
Fig.7: ‘Organosilicon epitope  (ChEBI: 59555) - an
organosilicon compound with a piperidine N-oxide core.
‘Fig.5: Steroidal epitope (ChEBI: 8884) - an epitope
with a 3α-hydroxy steroid skeleton.
